Literature DB >> 17204721

Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.

Andrew Quon1, Nancy J Fischbein, I Ross McDougall, Quynh-Thu Le, Billy W Loo, Harlan Pinto, Michael J Kaplan.   

Abstract

18F-FDG PET/CT has rapidly become a widely used imaging modality for evaluating a variety of malignancies, including squamous cell carcinoma of the head and neck and thyroid cancer. Using both published data and the multidisciplinary experience at our institution, we provide a practical set of guidelines and algorithms for the use of 18F-FDG PET/CT in the evaluation and management of head and neck cancer and thyroid cancer.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17204721

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  21 in total

Review 1.  The role of FDG PET-CT in the therapeutic evaluation for HNSCC patients.

Authors:  Joji Kawabe; Shigeaki Higashiyama; Atsushi Yoshida; Kohei Kotani; Susumu Shiomi
Journal:  Jpn J Radiol       Date:  2012-04-05       Impact factor: 2.374

Review 2.  Positron emission tomography for benign and malignant disease.

Authors:  Anthony Visioni; Julian Kim
Journal:  Surg Clin North Am       Date:  2011-02       Impact factor: 2.741

3.  Prognostic value of post-treatment (18)F-FDG PET/CT for advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy.

Authors:  Kimiteru Ito; Keigo Shimoji; Yoko Miyata; Kouhei Kamiya; Ryogo Minamimoto; Kazuo Kubota; Momoko Okasaki; Miyako Morooka; Jyunkichi Yokoyama
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

Review 4.  (18)F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applications.

Authors:  Gianpiero Manca; Eleonora Vanzi; Domenico Rubello; Francesco Giammarile; Gaia Grassetto; Ka Kit Wong; Alan C Perkins; Patrick M Colletti; Duccio Volterrani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-19       Impact factor: 9.236

5.  Focal dose escalation using FDG-PET-guided intensity-modulated radiation therapy boost for postoperative local recurrent rectal cancer: a planning study with comparison of DVH and NTCP.

Authors:  Keiichi Jingu; Hisanori Ariga; Tomohiro Kaneta; Yoshihiro Takai; Ken Takeda; Lindel Katja; Kakutaro Narazaki; Takahiro Metoki; Keisuke Fujimoto; Rei Umezawa; Yoshihiro Ogawa; Kenji Nemoto; Masashi Koto; Masatoshi Mitsuya; Naruhiro Matsufuji; Shoki Takahashi; Shogo Yamada
Journal:  BMC Cancer       Date:  2010-04-07       Impact factor: 4.430

6.  18F-FET PET/CT in advanced head and neck squamous cell carcinoma: an intra-individual comparison with 18F-FDG PET/CT.

Authors:  Stephan Kurt Haerle; Dorothee R Fischer; Daniel T Schmid; Nader Ahmad; Gerhard F Huber; Alfred Buck
Journal:  Mol Imaging Biol       Date:  2011-10       Impact factor: 3.488

Review 7.  Use of PET in Head and Neck Cancers.

Authors:  Halil Erdem Özel
Journal:  Turk Arch Otorhinolaryngol       Date:  2015-06-01

8.  Benign ulceration as a manifestation of soft tissue radiation necrosis: imaging findings.

Authors:  J M Debnam; A S Garden; L E Ginsberg
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-17       Impact factor: 3.825

9.  Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer.

Authors:  Akram Al-Ibraheem; Andreas Buck; Bernd Joachim Krause; Klemens Scheidhauer; Markus Schwaiger
Journal:  J Oncol       Date:  2009-08-20       Impact factor: 4.375

Review 10.  Multimodality imaging of head and neck cancer.

Authors:  A D King
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.